1. Home
  2. OOMA vs ZURA Comparison

OOMA vs ZURA Comparison

Compare OOMA & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$17.02

Market Cap

517.6M

Sector

Technology

ML Signal

HOLD

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$3.44

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
ZURA
Founded
2003
2022
Country
United States
United States
Employees
N/A
40
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
517.6M
455.4M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
OOMA
ZURA
Price
$17.02
$3.44
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$18.77
$13.00
AVG Volume (30 Days)
304.4K
656.9K
Earning Date
05-27-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
188.46
N/A
EPS
0.23
N/A
Revenue
$114,490,000.00
N/A
Revenue This Year
$20.35
N/A
Revenue Next Year
$4.17
N/A
P/E Ratio
$75.17
N/A
Revenue Growth
9.53
N/A
52 Week Low
$9.79
$1.00
52 Week High
$21.96
$7.25

Technical Indicators

Market Signals
Indicator
OOMA
ZURA
Relative Strength Index (RSI) 44.85 25.83
Support Level $10.78 $3.33
Resistance Level $19.56 $4.12
Average True Range (ATR) 0.97 0.31
MACD -0.33 -0.04
Stochastic Oscillator 15.50 12.25

Price Performance

Historical Comparison
OOMA
ZURA

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that delivers voice and collaboration features, including messaging, intelligent virtual attendants, and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: